「code」の検索結果
20件：6～10件目を表示
-
sed to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
nnounces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
sed to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
ka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
nnounces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf